Ultralife (ULBI) Cash & Current Investments (2010 - 2026)

Ultralife has reported Cash & Current Investments for 17 years, with the latest figure at $8.9 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Current Investments rose 1.96% year-over-year to $8.9 million; the trailing twelve-month figure through Mar 2026 stood at $8.9 million (up 1.96% YoY), and the FY2025 full-year result was $9.3 million, up 36.34% from the prior year.
• Cash & Current Investments for Q1 2026 stood at $8.9 million, down from $9.3 million in the prior quarter.
• The five-year high for Cash & Current Investments was $10.9 million in Q2 2025, with the low at $5.1 million in Q3 2022.
• Average Cash & Current Investments over 5 years is $7.8 million, with a median of $8.3 million recorded in 2023.
• Year-over-year, Cash & Current Investments slumped 68.14% in 2022 and soared 84.14% in 2023.
• Tracing ULBI's Cash & Current Investments over 5 years: stood at $5.7 million in 2022, then soared by 79.91% to $10.3 million in 2023, then slumped by 33.31% to $6.9 million in 2024, then surged by 36.34% to $9.3 million in 2025, then decreased by 4.87% to $8.9 million in 2026.
• The last three Cash & Current Investments figures came in at $8.9 million (Q1 2026), $9.3 million (Q4 2025), and $9.3 million (Q3 2025), per Business Quant data.

Peer Comparison